{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:47:06Z","timestamp":1787917626637,"version":"build-2784847793"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>\n                    Ki-67 proliferation indices (PIs) define the grading of GastroEnteroPancreatic NeuroEndocrine Neoplasms (GEPNENs) and are crucial for therapeutic decisions. The precise Ki-67 assessment relies on manual counting, which is time-consuming, hardly accessible during routine pathological signout and thus usually replaced by the easier eye-estimation\/balling method prone to interobserver variability and differences originating from the hot-spot size, localisation and tumor heterogeneity. These discrepancies can significantly affect the final PI resulting in misgrading of GEPNENs with potential adverse patient outcomes. In the era of digital pathology more and more applications are available to overcome this problem. In our retrospective study of 60 surgically resected GEPNEN cases, we tested the equivalence of traditional clinical (C) grading, manual counting with a MarkerCounter (MC) application and automatic grading with tumor recognition PatternQuant application with subsequent NuclearQuant (NQ) PI-assessment within 3DHistechs digital pathology platform. We found almost perfect agreement between the various grading methods (Spearman rank-order correlations: C vs. MC:\n                    <jats:italic>\u03c1<\/jats:italic>\n                    = 0.912, C vs. NQ:\n                    <jats:italic>\u03c1<\/jats:italic>\n                    = 0.883, MC vs NQ:\n                    <jats:italic>\u03c1<\/jats:italic>\n                    = 0.953) without clinically significant misgradings. Also the numerical values of the PIs derived with the various methods showed close correlations (Linear regression: C vs. MC:\n                    <jats:italic>r<\/jats:italic>\n                    = 0.952, C vs. NQ:\n                    <jats:italic>r<\/jats:italic>\n                    = 0.925, MC vs NQ:\n                    <jats:italic>r<\/jats:italic>\n                    = 0.978). The automated PI-assessment involved a mean 5-fold more tumor cells, better approximating the global\/total Ki-67 PI, which was earlier shown to deliver more robust prognostic power and decreased interobserver variability. Furthermore, G3 tumors differed from G2 and G1 tumors in their cytomorphological parameterers: high grade tumors had significantly larger and more polymorphic, less regular tumor cell nuclei, which parameters could be also utilized for grading and\/or prognostication purposes. Our study applied a simple, quick, easy-to-use, Machine Learning-based method that could be incorporated into routine digital pathology signout alleviating pathologists\u2019 workload and increasing precision and recall rate.\n                  <\/jats:p>","DOI":"10.3389\/pore.2025.1612248","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:10:17Z","timestamp":1767766217000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Digitally derived Ki-67 proliferation index for GastroEnteroPancreatic neuroendocrine neoplasms"],"prefix":"10.3389","volume":"31","author":[{"given":"Tam\u00e1s","family":"Micsik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Csell\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d V.","family":"Patai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jakab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"J\u00f3n\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/PAI.0000000000000934","article-title":"Digital image analysis of the proliferation markers Ki-67 and phosphohistone H3 in gastroenteropancreatic neuroendocrine neoplasms: accuracy of grading compared with routine manual hot spot evaluation of the Ki-67 index","volume":"29","author":"Lea","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical Practice Guidelines for diagnosis. Treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00428-017-2258-0","article-title":"Ki-67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms","volume":"472","author":"Kl\u00f6ppel","year":"2018","journal-title":"Virchows Arch"},{"key":"B4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1097\/PAS.0000000000000089","article-title":"Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki-67 proliferative index and mitotic rate","volume":"37","author":"McCall","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12022-015-9379-2","article-title":"Comparison of three Ki-67 index quantification methods and clinical significance in pancreatic rs","volume":"26","author":"Kroneman","year":"2015","journal-title":"Endocr Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/modpathol.2014.156","article-title":"Calculation of the Ki-67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies","volume":"28","author":"Reid","year":"2015","journal-title":"Mod Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/PAS.0b013e318272ff77","article-title":"Ki-67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question. But rather how to count","volume":"36","author":"Adsay","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/PAS.0b013e31821a0696","article-title":"Effect of tumor heterogeneity on the assessment of Ki-67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification","volume":"35","author":"Yang","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10549-020-05752-w","article-title":"Prognostic potential of automated Ki-67 evaluation in breast cancer: different hot spot definitions versus true global score","volume":"183","author":"Robertson","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"B11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/his.14200","article-title":"Comparison of different anti-Ki-67 antibody clones and hot-spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis","volume":"77","author":"Owens","year":"2020","journal-title":"Histopathology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/diagnostics12081960","article-title":"Proposal for a new diagnostic histopathological approach in the evaluation of Ki-67 in GEP-NETs","volume":"12","author":"Faviana","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12022-023-09755-3","article-title":"Diagnostic. Prognostic. And predictive role of Ki-67 proliferative index in neuroendocrine and endocrine neoplasms: past. Present. And future","volume":"34","author":"La","year":"2023","journal-title":"Endocr Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ajcp\/aqaa275","article-title":"Ki-67 proliferation index assessment in gastroenteropancreatic neuroendocrine tumors by digital image analysis with stringent case and hotspot level concordance requirements","volume":"156","author":"Boukhar","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"151586","DOI":"10.1016\/j.anndiagpath.2020.151586","article-title":"Ki-67 index and mitotic count: correlation and variables affecting the accuracy of the quantification in endocrine\/neuroendocrine tumors","volume":"48","author":"Huang","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12022-018-9554-3","article-title":"Comparison of monitor-image and printout-image methods in Ki-67 scoring of gastroenteropancreatic neuroendocrine tumors","volume":"30","author":"Dogukan","year":"2019","journal-title":"Endocr Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jasc.2016.03.002","article-title":"Grading pancreatic neuroendocrine neoplasms by Ki-67 staining on cytology cell blocks: manual count and digital image analysis of 58 cases","volume":"5","author":"Jin","year":"2016","journal-title":"J Am Soc Cytopathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41379-022-01055-1","article-title":"Ki-67 assessment of pancreatic neuroendocrine neoplasms: systematic review and meta-analysis of manual vs. digital pathology scoring","volume":"35","author":"Luchini","year":"2022","journal-title":"Mod Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s12282-018-0885-1","article-title":"Comparison of Ki-67 labeling index measurements using digital image analysis and scoring by pathologists","volume":"25","author":"Morioka","year":"2018","journal-title":"Breast Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/ajcp\/aqx154","article-title":"Comparison of a medical-grade monitor vs commercial off-the-shelf display for mitotic figure enumeration and small object (Helicobacter pylori) detection","volume":"149","author":"Norgan","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/PAS.0b013e318263207c","article-title":"Objective quantification of the Ki-67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods","volume":"36","author":"Tang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42047-019-0045-8","article-title":"Kuga FS. Del Carlo Bernardi F. Comparation of the quantification of the proliferative index KI-67 between eyeball and semi-automated digital analysis in gastro-intestinal neuroendrocrine tumors","volume":"2","author":"Basile","year":"2019","journal-title":"Surg Exp Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jmi.12176","article-title":"Perceptual clustering for automatic hotspot detection from Ki-67-stained neuroendocrine tumour images","volume":"256","author":"Khan","year":"2014","journal-title":"J Microsc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"012704","DOI":"10.1117\/1.JMI.7.1.012704","article-title":"Histopathologist-level quantification of Ki-67 immunoexpression in gastroenteropancreatic neuroendocrine tumors using semiautomated method","volume":"7","author":"Saadeh","year":"2020","journal-title":"J Med Imaging (Bellingham)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"152295","DOI":"10.1016\/j.anndiagpath.2024.152295","article-title":"Digital image analysis of Ki-67 hotspot detection and index counting in gastroenteropancreatic neuroendocrine neoplasms","volume":"71","author":"Saetiew","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jasc.2024.02.001","article-title":"Automated imaging analysis of Ki-67 immunohistochemistry on whole slide images of cell blocks from pancreatic neuroendocrine neoplasms","volume":"13","author":"Shaker","year":"2024","journal-title":"J Am Soc Cytopathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/apm.13190","article-title":"Automated assessment of Ki-67 proliferation index in neuroendocrine tumors by deep learning","volume":"130","author":"Vesterinen","year":"2022","journal-title":"Apmis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fmolb.2020.00183","article-title":"Predict Ki-67 positive cells in H&E-stained images using deep learning independently from IHC-stained images","volume":"7","author":"Liu","year":"2020","journal-title":"Front Mol Biosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11604-022-01262-5","article-title":"Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors","volume":"40","author":"Xie","year":"2022","journal-title":"Jpn J Radiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/PAP.0000000000000263","article-title":"Clinical application of image analysis in pathology","volume":"27","author":"Cornish","year":"2020","journal-title":"Adv Anat Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.1038\/s41598-020-67880-z","article-title":"Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning","volume":"10","author":"Govind","year":"2020","journal-title":"Sci Rep"},{"key":"B32","first-page":"225","article-title":"Clinicopathologic characteristics of neuroendocrine tumors with assessment by digital image analysis for Ki-67 index with a focus on the gastroenteropancreatic tract: a single-center study","volume":"16","author":"Park","year":"2023","journal-title":"Int J Clin Exp Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cncy.22272","article-title":"Ki-67 proliferation index in neuroendocrine tumors: can augmented reality microscopy with image analysis improve scoring?","volume":"128","author":"Satturwar","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000367713","article-title":"Sanders J. Prins FA. van der Noort V. Korse CM. Reliability of proliferation assessment by Ki-67 expression in neuroendocrine neoplasms: eyeballing or image analysis?","volume":"100","author":"van Velthuysen","year":"2014","journal-title":"Neuroendocrinology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/jpi.jpi_76_18","article-title":"Ki-67 quantitative interpretation: insights using image analysis","volume":"10","author":"Volynskaya","year":"2019","journal-title":"J Pathol Inform"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s11517-024-03045-8","article-title":"Automated AI-based grading of neuroendocrine tumors using Ki-67 proliferation index: comparative evaluation and performance analysis","volume":"62","author":"Y\u00fccel","year":"2024","journal-title":"Med Biol Eng Comput"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1016\/j.modpat.2022.100017","article-title":"Digital image analysis of Ki-67 heterogeneity improves the diagnosis and prognosis of gastroenteropancreatic neuroendocrine neoplasms","volume":"36","author":"Zhang","year":"2023","journal-title":"Mod Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3322\/caac.21493","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B40","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1309\/AJCP92UCXPJMMSDU","article-title":"Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors","volume":"137","author":"Goodell","year":"2012","journal-title":"Am J Clin Pathol"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2025.1612248\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:10:18Z","timestamp":1767766218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2025.1612248\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":40,"alternative-id":["10.3389\/pore.2025.1612248"],"URL":"https:\/\/doi.org\/10.3389\/pore.2025.1612248","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1612248"}}